???global.info.a_carregar???
Marta Sofia Carvalho Teixeira Pinto (MTP; MSc Neurosciences, 2001; PhD.Human Biology, 2008) Joined IPATIMUP (www.ipatimup.pt) as an Investigator Ciência 2008 (2009) of the Cancer Genetics Group and was mainly dedicated to study cancer angiogenesis, invasion and metastasis, using chick embryo chorioallantoid membrane (CAM) model. After setting up the laboratory, and implementing several fundamental assays, MTP established the “In vivo CAM assays Scientific Platform” (2012), currently coordinated and managed by MTP (www.i3s.up.pt). The portfolio of available CAM assays now covers other fields of study besides cancer. In particular, the study of biomaterials, proteins and permeability assays. MTP published 36 papers in international peer reviewed journals, all in Q1 journals, with an H index of 16 (ResearcherID: J-2519-2013) and received 7 awards and/or honors.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Marta Sofia Carvalho Teixeira Pinto

Identificadores de autor

Ciência ID
8416-F65B-D094
ORCID iD
0000-0002-8521-2904
Researcher Id
J-2519-2013
Formação
Grau Classificação
2019/10 - 2020/06
Concluído
 Postgraduate Course in Science and Technology Management and Policy (Curso de Especialização Tecnológica)
Universidade Nova de Lisboa Faculdade de Ciências Sociais e Humanas, Portugal
 17
2002 - 2008/02/25
Concluído
 Biologia Humana (Doutoramento)
Especialização em Sem especialidade
Universidade do Porto Faculdade de Medicina, Portugal
"Modificações do Sistema Endógeno de Controlo da Dor em Processos Dolorosos Agudos e Crónicos" (TESE/DISSERTAÇÃO)
1999/09 - 2001/06
Concluído
 Neurociências (Mestrado integrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
1994/09 - 1999/06
Concluído
 Bioquímica (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
Percurso profissional

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/01 - Atual Carreiras / Categorias Subsistentes Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2015/06/01 - 2023/01 Carreiras / Categorias Subsistentes Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2014/06/01 - 2015/06/30 Investigador Doutorado (projecto NORTE-07-0124-FEDER-000022) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2009/06/01 - 2014/05/31 Investigator - Ciência 2008 Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2008/02/01 - 2009/05/01 Invited Auxiliar Professor. Disciplines: Molecular Biology, Metabolic Biochemistry and Genetics. Responsible for the organization and teaching of the module of Gene Therapy, integrated in the masters Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2007/09/01 - 2008/02/01 Invited Assistant Professor. Discipline: Genetics (theoretical, practical and theorico-practical) and Molecular Biology. Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2002/03/01 - 2008/02/01 PhD Student Universidade do Porto Faculdade de Medicina, Portugal
2004/11/01 - 2007/11/01 Monitor (Monitora). Discipline: Cellular and Molecular Biology Universidade do Porto Faculdade de Medicina, Portugal
2003/02/01 - 2007/07/01 Master Assistant Professor (Mestre Assistente). Disciplines: Laboratorial techniques, Cytological techniques I and Immunology (practical classes) Universidade Fernando Pessoa, Portugal
1999/10/01 - 2001/11/01 Master Student Universidade de Lisboa Faculdade de Medicina, Portugal
Projetos

Bolsa

Designação Financiadores
2018 - 2020 Predicting patients' response to liposomal anticancer drugs: focusing on LRP1B endocytic activity.
PTDC/MEC-ONC/31520/2017
Outra
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013 - 2016 Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation.
PTDC/BBB-BIO/1240/2012
2010 - 2013 Tumour spectrum in Hereditary Diffuse Gastric Cancer
PTDC/SAU-ONC/110294/2009
Outra

Projeto

Designação Financiadores
2015 - Atual Funding of RD Units Strategic Plan - 2013/2015 - OE
UID/BIM/04293/2013
Outra
2014 - Atual Projectos de IC&DT Estratégicos e de Interesse Público promovidos por Laboratórios Associados e Unidades de I&D - 2013 - COMPETE
PEst-C/SAU/LA0003/2013
Outra

Outro

Designação Financiadores
2021/03/01 - 2024/02/28 Drug Repurposing from cancer therapy to control of infections.
PTDC/BIA-MIC/5343/2020
Desenvolvimento técnico
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Em curso
Produções

Publicações

Artigo em revista
  1. Padrão, Tatiana; Dias, Joana; Carvalho, Ângela; Pinto, Marta T.; Monteiro, Fernando J.; Sousa, Susana R.. "Vancomycin-loaded bone substitute as a ready-to-use drug delivery system to treat osteomyelitis". Ceramics International 49 15 (2023): 24771-24782. http://dx.doi.org/10.1016/j.ceramint.2023.04.239.
    10.1016/j.ceramint.2023.04.239
  2. Joana Peixoto; Catarina Príncipe; Ana Pestana; Hugo Osório; Marta Teixeira Pinto; Hugo Prazeres; Paula Soares; et al. "Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma". International Journal of Molecular Sciences 24 14 (2023): 11285. https://doi.org/10.3390/ijms241411285.
    10.3390/ijms241411285
  3. Rita Mota; Raquel T. Lima; Carlos Flores; Juliana F. Silva; Beatriz Cruz; Bárbara Couto Viana Alves; Marta T. Pinto; et al. "Assessing the Antitumor Potential of Variants of the Extracellular Carbohydrate Polymer from Synechocystis ¿sigF Mutant". Polymers 15 6 (2023): 1382-1382. http://dx.doi.org/10.3390/polym15061382.
    10.3390/polym15061382
  4. Wendy Malespín-Bendaña; Rui M. Ferreira; Marta T. Pinto; Ceu Figueiredo; Warner Alpízar-Alpízar; Clas Une; Lucía Figueroa-Protti; Vanessa Ramírez. "Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line". Brazilian Journal of Microbiology (2023): http://dx.doi.org/10.1007/s42770-023-00940-4.
    10.1007/s42770-023-00940-4
  5. Dagmar Fischer; Georg Fluegen; Paul Garcia; Nassim Ghaffari-Tabrizi-Wizsy; Gribaldo Laura; Ruby Yun-Ju Huang; Volker Rasche; et al. "The CAM Model—Q&A with Experts". Cancers 15 1 (2022): 191-191. http://dx.doi.org/10.3390/cancers15010191.
    10.3390/cancers15010191
  6. Morena Francesca Fiordalisi; Joana Rita Ferreira; Marta Laranjeiro Pinto; Cláudia Ribeiro-Machado; Marta Teixeira Pinto; Maria José Oliveira; Mário Adolfo Barbosa; Raquel Madeira Gonçalves; Joana Caldeira. "The impact of matrix age on intervertebral disc regeneration". Biomaterials Advances 143 (2022): 213192-213192. http://dx.doi.org/10.1016/j.bioadv.2022.213192.
    10.1016/j.bioadv.2022.213192
  7. Sara Baptista-Silva; Beatriz G. Bernardes; Sandra Borges; Ilda Rodrigues; Rui Fernandes; Susana Gomes-Guerreiro; Marta Pinto; et al. "Exploring Silk Sericin for Diabetic Wounds: An In Situ-Forming Hydrogel to Protect against Oxidative Stress and Improve Tissue Healing and Regeneration". Biomolecules 12 6 (2022): 801-801. http://dx.doi.org/10.3390/biom12060801.
    10.3390/biom12060801
  8. Igor Tokarchuk; Félice A. Janser; Anna M. Schläfli; Marta Teixeira Pinto; Magali Humbert; Nicolas J. Niklaus; Sabina Berezowska; Rupert Langer; Mario P. Tschan. "Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viability". Biochemical and Biophysical Research Communications (2021): https://doi.org/10.1016/j.bbrc.2021.06.082.
    10.1016/j.bbrc.2021.06.082
  9. "The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness". Cancers 13 6 (2021): 1330-1330. http://dx.doi.org/10.3390/cancers13061330.
    10.3390/cancers13061330
  10. Pinto, MT; Pinto, Marta Teixeira; Ribeiro, Ana Sofia; Conde, Inês; Carvalho, Rita; Paredes, Joana. "The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity". International Journal of Molecular Sciences 22 1 (2020): 334-334. http://dx.doi.org/10.3390/ijms22010334.
    10.3390/ijms22010334
  11. Pinto, MT. "The antibacterial and angiogenic effect of magnesium oxide in a hydroxyapatite bone substitute". Scientific Reports 10 1 (2020): http://dx.doi.org/10.1038/s41598-020-76063-9.
    10.1038/s41598-020-76063-9
  12. Pinto, MT. "BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer". Cells 9 11 (2020): 2442-2442. http://dx.doi.org/10.3390/cells9112442.
    10.3390/cells9112442
  13. Pinto, Marta. "Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions". Cells (2020): http://dx.doi.org/10.3390/cells9020513.
    10.3390/cells9020513
  14. Loureiro, J.; Torres, A.L.; Neto, T.; Aguiar, P.; Barrias, C.C.; Pinto, M.T.; Amaral, I.F.. "Corrigendum to “Conjugation of the T1 sequence from CCN1 to fibrin hydrogels for therapeutic vascularization” [Mater. Sci. & Eng. C. 104 (2019) 109847](S092849311930548X)(10.1016/j.msec.2019.109847)". Materials Science and Engineering C 108 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85076046977&partnerID=MN8TOARS.
    10.1016/j.msec.2019.110514
  15. Pinto, Marta. "Conjugation of the T1 sequence from CCN1 to fibrin hydrogels for therapeutic vascularization". Materials Science and Engineering: C (2019): http://dx.doi.org/10.1016/j.msec.2019.109847.
    10.1016/j.msec.2019.109847
  16. Pinto, Marta; Marques, F.G.; Poli, E.; Rino, J.; Pinto, M.T.; Diegues, I.; Pina, F.; Rosa Santos, S.C.. "Low Doses of Ionizing Radiation Enhance the Angiogenic Potential of Adipocyte Conditioned Medium". Radiation Research 192 5 (2019): 517-526. http://dx.doi.org/10.1667/rr15438.1.
    10.1667/rr15438.1
  17. Pinto, Marta. "O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype.". EBioMedicine (2019): http://europepmc.org/articles/PMC6413340.
    10.1016/j.ebiom.2019.01.017
  18. Pinto, Marta. "The Chick Chorioallantoic Membrane (CAM) Assay as a Three-dimensional Model to Study Autophagy in Cancer Cells". BIO-PROTOCOL (2019): http://dx.doi.org/10.21769/bioprotoc.3290.
    10.21769/bioprotoc.3290
  19. Pinto, Marta. "Codon misreading tRNAs promote tumor growth in mice". RNA Biology (2018): http://dx.doi.org/10.1080/15476286.2018.1454244.
    10.1080/15476286.2018.1454244
  20. Torres, A.L.; Bidarra, S.J.; Pinto, M.T.; Aguiar, P.C.; Silva, E.A.; Barrias, C.C.. "Guiding morphogenesis in cell-instructive microgels for therapeutic angiogenesis". Biomaterials 154 (2018): 34-47. http://www.scopus.com/inward/record.url?eid=2-s2.0-85032820887&partnerID=MN8TOARS.
    10.1016/j.biomaterials.2017.10.051
  21. Pópulo, H.; Nunes, B.; Sampaio, C.; Batista, R.; Pinto, M.T.; Gaspar, T.B.; Miranda-Alves, L.; et al. "Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer". Hormones and Cancer 8 5-6 (2017): 314-324. http://www.scopus.com/inward/record.url?eid=2-s2.0-85029580437&partnerID=MN8TOARS.
    10.1007/s12672-017-0307-4
  22. Ribeiro-Rodrigues, T.M.; Laundos, T.L.; Pereira-Carvalho, R.; Batista-Almeida, D.; Pereira, R.; Coelho-Santos, V.; Silva, A.P.; et al. "Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis". Cardiovascular Research 113 11 (2017): 1338-1350. http://www.scopus.com/inward/record.url?eid=2-s2.0-85030638942&partnerID=MN8TOARS.
    10.1093/cvr/cvx118
  23. Olivera-Severo, D.; Uberti, A.F.; Marques, M.S.; Pinto, M.T.; Gomez-Lazaro, M.; Figueiredo, C.; Leite, M.; Carlini, C.R.. "A new role for Helicobacter pylori urease: Contributions to angiogenesis". Frontiers in Microbiology 8 SEP (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85030183952&partnerID=MN8TOARS.
    10.3389/fmicb.2017.01883
  24. Pinto, Marta. "Corrigendum: Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells (Oncogene (2010) 30 (1302-1317) DOI: 10.1038/onc.2010.512)". Oncogene 36 1 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85008937066&partnerID=MN8TOARS.
    10.1038/onc.2016.143
  25. Resende, C.; Regalo, G.; Durães, C.; Pinto, M.T.; Wen, X.; Figueiredo, C.; Carneiro, F.; Machado, J.C.. "Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPß-associated mechanism". Gastric Cancer 19 1 (2016): 74-84. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951569926&partnerID=MN8TOARS.
    10.1007/s10120-014-0448-x
  26. Teresa Pinto, A.; Laranjeiro Pinto, M.; Patrícia Cardoso, A.; Monteiro, C.; Teixeira Pinto, M.; Filipe Maia, A.; Castro, P.; et al. "Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities". Scientific Reports 6 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84954288518&partnerID=MN8TOARS.
    10.1038/srep18765
  27. Estrada, M.F.; Rebelo, S.P.; Davies, E.J.; Pinto, M.T.; Pereira, H.; Santo, V.E.; Smalley, M.J.; et al. "Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression". Biomaterials 78 (2016): 50-61. http://www.scopus.com/inward/record.url?eid=2-s2.0-84949946054&partnerID=MN8TOARS.
    10.1016/j.biomaterials.2015.11.030
  28. Pinto, A.T.; Pinto, M.L.; Velho, S.; Pinto, M.T.; Cardoso, A.P.; Figueira, R.; Monteiro, A.; et al. "Intricate macrophage-colorectal cancer cell communication in response to radiation". PLoS ONE 11 8 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84983567727&partnerID=MN8TOARS.
    10.1371/journal.pone.0160891
  29. Almeida, M.I.; Silva, A.M.; Vasconcelos, D.M.; Almeida, C.R.; Caires, H.; Pinto, M.T.; Calin, G.A.; Santos, S.G.; Barbosa, M.A.. "miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis". Oncotarget 7 1 (2016): 7-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-84969765513&partnerID=MN8TOARS.
    10.18632/oncotarget.6589
  30. Ferreira, L.B.; Tavares, C.; Pestana, A.; Pereira, C.L.; Eloy, C.; Pinto, M.T.; Castro, P.; et al. "Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior". Oncotarget 7 32 (2016): 52003-52016. http://www.scopus.com/inward/record.url?eid=2-s2.0-84982293109&partnerID=MN8TOARS.
    10.18632/oncotarget.10468
  31. Cardoso, A.P.; Pinto, M.L.; Pinto, A.T.; Pinto, M.T.; Monteiro, C.; Oliveira, M.I.; Santos, S.G.; et al. "Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour". BMC Cancer 15 1 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84930669986&partnerID=MN8TOARS.
    10.1186/s12885-015-1466-8
  32. Caldeira, J.; Figueiredo, J.; Brás-Pereira, C.; Carneiro, P.; Moreira, A.M.; Pinto, M.T.; Relvas, J.B.; et al. "E-cadherin-defective gastric cancer cells depend on Laminin to survive and invade". Human Molecular Genetics 24 20 (2015): 5891-5900. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943762566&partnerID=MN8TOARS.
    10.1093/hmg/ddv312
  33. Simões-correia, J.; Silva, D.I.; Melo, S.; Figueiredo, J.; Caldeira, J.; Pinto, M.T.; Girão, H.; Pereira, P.; Seruca, R.. "DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo". Human Molecular Genetics 23 8 (2014): 2094-2105. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897831766&partnerID=MN8TOARS.
    10.1093/hmg/ddt602
  34. Cardoso, A.P.; Pinto, M.L.; Pinto, A.T.; Oliveira, M.I.; Pinto, M.T.; Gonçalves, R.; Relvas, J.B.; et al. "Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y 1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity". Oncogene 33 16 (2014): 2123-2133. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899425243&partnerID=MN8TOARS.
    10.1038/onc.2013.154
  35. Gomes, C.; Osório, H.; Pinto, M.T.; Campos, D.; Oliveira, M.J.; Reis, C.A.. "Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells". PLoS ONE 8 6 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84879165131&partnerID=MN8TOARS.
    10.1371/journal.pone.0066737
  36. Pinheiro, H.; Carvalho, J.; Oliveira, P.; Ferreira, D.; Pinto, M.T.; Osoquot;rio, H.; Licastro, D.; et al. "Transcription initiation arising from E-cadherin/CDH1 intron2: A novel protein isoform that increases gastric cancer cell invasion and angiogenesis". Human Molecular Genetics 21 19 (2012): 4253-4269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866408689&partnerID=MN8TOARS.
    10.1093/hmg/dds248
  37. Caldeira, J.; Simões-Correia, J.; Paredes, J.; Pinto, M.T.; Sousa, S.; Corso, G.; Marrelli, D.; et al. "CPEB1, a novel gene silenced in gastric cancer: A Drosophila approach". Gut 61 8 (2012): 1115-1123. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863719147&partnerID=MN8TOARS.
    10.1136/gutjnl-2011-300427
  38. Prazeres, H.; Torres, J.; Rodrigues, F.; Pinto, M.; Pastoriza, M.C.; Gomes, D.; Cameselle-Teijeiro, J.; et al. "Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells". Oncogene 30 11 (2011): 1302-1317. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952775150&partnerID=MN8TOARS.
    10.1038/onc.2010.512
  39. Pinto, M.; Soares, P.; Ribatti, D.. "Thyroid hormone as a regulator of tumor induced angiogenesis". Cancer Letters 301 2 (2011): 119-126. http://www.scopus.com/inward/record.url?eid=2-s2.0-78651448387&partnerID=MN8TOARS.
    10.1016/j.canlet.2010.11.011
  40. Ribeiro, M.M.B.; Pinto, A.; Pinto, M.; Heras, M.; Martins, I.; Correia, A.; Bardaji, E.; Tavares, I.; Castanho, M.. "Inhibition of nociceptive responses after systemic administration of amidated kyotorphin". British Journal of Pharmacology 163 5 (2011): 964-973. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955630518&partnerID=MN8TOARS.
    10.1111/j.1476-5381.2011.01290.x
  41. Marques-Lopes, J.; Pinto, M.; Pinho, D.; Morato, M.; Patinha, D.; Albino-Teixeira, A.; Tavares, I.. "Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia". Neuroscience 158 4 (2009): 1301-1310. http://www.scopus.com/inward/record.url?eid=2-s2.0-60149095326&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2008.11.044
  42. Pinto, M.; Castro, A.R.; Tshudy, F.; Wilson, S.P.; Lima, D.; Tavares, I.. "Opioids modulate pain facilitation from the dorsal reticular nucleus". Molecular and Cellular Neuroscience 39 4 (2008): 508-518. http://www.scopus.com/inward/record.url?eid=2-s2.0-56249149196&partnerID=MN8TOARS.
    10.1016/j.mcn.2008.07.008
  43. Pinto, M.; Sousa, M.; Lima, D.; Tavares, I.. "Participation of µ-opioid, GABAB, and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: Implications for descending modulation of nociceptive transmission". Journal of Comparative Neurology 510 2 (2008): 175-187. http://www.scopus.com/inward/record.url?eid=2-s2.0-50249092715&partnerID=MN8TOARS.
    10.1002/cne.21793
  44. Martins, I.; Pinto, M.; Wilson, S.P.; Lima, D.; Tavares, I.. "Dynamic of migration of HSV-1 from a medullary pronociceptive centre: Antinociception by overexpression of the preproenkephalin transgene". European Journal of Neuroscience 28 10 (2008): 2075-2083. http://www.scopus.com/inward/record.url?eid=2-s2.0-55949120169&partnerID=MN8TOARS.
    10.1111/j.1460-9568.2008.06492.x
  45. Pinto, M.; Lima, D.; Tavares, I.. "Neuronal activation at the spinal cord and medullary pain control centers after joint stimulation: A c-fos study in acute and chronic articular inflammation". Neuroscience 147 4 (2007): 1076-1089. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547118578&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2007.05.019
  46. Castro, A.R.; Pinto, M.; Lima, D.; Tavares, I.. "Secondary hyperalgesia in the monoarthritic rat is mediated by GABABand NK1 receptors of spinal dorsal horn neurons: A behavior and c-fos study". Neuroscience 141 4 (2006): 2087-2095. http://www.scopus.com/inward/record.url?eid=2-s2.0-33747161263&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2006.05.048
  47. Pinto, M.; Lima, D.; Tavares, I.. "Correlation of noxious evoked c-fos expression in areas of the somatosensory system during chronic pain: Involvement of spino-medullary and intra-medullary connections". Neuroscience Letters 409 2 (2006): 100-105. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750378060&partnerID=MN8TOARS.
    10.1016/j.neulet.2006.08.031
  48. Castro, A.R.; Pinto, M.; Lima, D.; Tavares, I.. "Imbalance between the expression of NK1 and GABABreceptors in nociceptive spinal neurons during secondary hyperalgesia: A c-Fos study in the monoarthritic rat". Neuroscience 132 4 (2005): 905-916. http://www.scopus.com/inward/record.url?eid=2-s2.0-18044366195&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2005.01.048
  49. Castro, A.R.; Pinto, M.; Lima, D.; Tavares, I.. "Nociceptive spinal neurons expressing NK1 and GABABreceptors are located in lamina I". Brain Research 1003 1-2 (2004): 77-85. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542298862&partnerID=MN8TOARS.
    10.1016/j.brainres.2003.12.027
  50. Pinto, M.; Lima, D.; Castro-Lopes, J.; Tavares, I.. "Noxious-evoked c-fos expression in brainstem neurons immunoreactive for GABAB, µ-opioid and nk-1 receptors". European Journal of Neuroscience 17 7 (2003): 1393-1402. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038706314&partnerID=MN8TOARS.
    10.1046/j.1460-9568.2003.02586.x
Capítulo de livro
  1. Pinto, Marta Teixeira; Ribeiro, Ana Sofia; Paredes, Joana. "The Chick CAM as an In Vivo System to Study Stem Cell Activity". In Methods in Molecular Biology, 155-166. Springer US, 2022.
    10.1007/978-1-0716-2703-7_12
Pré-impressão
  1. "Neuroprotection in early stages of Alzheimer’s Disease is promoted by Transthyretin angiogenic properties". 2021. http://dx.doi.org/10.1101/2021.04.16.440131.
    10.1101/2021.04.16.440131
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2024/02/05 Hatching a CAM-dedicated scientific platform. II International CAM conference
(Alemanha)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2021/06 - 2023/10 Responsável pelo programa educativo do i3S CienciaETal (2021/06 - 2023/10)
Outro
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Arbitragem científica em conferência

Nome da conferência Local da conferência
2022/02 - 2024/02 II International CAM conference University Hospital Erlangen, Institute of Pathology, Experimental Tumorpathology, Erlangen, Germany

Membro de associação

Nome da associação Tipo de participação
2013 - Atual ASPIC

Revisão ad hoc de artigos em revista

Nome da revista (ISSN) Editora
2022 - 2023 Cancers
Distinções

Prémio

2013 IDDNET – Technology Network award - 1st prise Proof of Concept Arrisca C 2014
2010 Endocrinology National Award SPEDM/NOVARTIS ONCOLOGY-2010 - Hugo Prazeres, Marta Pinto, Joana Couto, Fernando Rodrigues, João Vinagre, Joana Torres, Vitor Trovisco, Teresa Martins, Manuel Sobrinho-Simões e Paula Soares. The lipoprotein receptor LRP1B su
Novartis Oncology, Estados Unidos
2006 Grünenthal Pain Award 2006 – Best investigation work - “Secondary hyperalgesia and the expression of NK1 and GABAB receptors in nociceptive spinal neurons. Actions of the supraspinal pain control system”
2005 Janssen/Astor Award - “Gene therapy for chronic pain control by manipulation of supraspinal centres”
2005 AstraZeneca Foundation Award 2005 - “The central nervous system during diabetic neuropathy: perspectives for gene therapy in pain control”
2004 International Investigation Award – 2nd honour mention - “Perspectives os gene therapy applications to chronic pain control”
Cooperativa de Ensino Superior Politécnico e Universitário, Portugal

Outra distinção

2014 Finalista do prémio da 16ª edição do Jovem Empreendedor (Expertus, CAM assays)